& Anti-Allergy Drugs publishes original
research, expert reviews, drug clinical trials and thematic
issues in all core areas of translational and clinical anti-inflammatory
& anti-allergy drug research.
The journal publishes pre-clinical and clinical studies
on the development of new anti-inflammatory & anti-allergy
agents. Clinical studies of new reported anti-inflammatory
& anti-allergy drugs include Phase 1 – IV clinical
trial studies, their designs, research methodologies, and
analyses. The journal is essential reading to clinicians,
toxicologists, medicinal chemists, and to pharmacologists.